Results 101 to 110 of about 2,457 (125)

Ivacaftor/lumacaftor

Reactions Weekly, 2017
  +9 more sources

Ivacaftor/lumacaftor

Reactions Weekly, 2019
  +8 more sources

Ivacaftor/lumacaftor

Reactions Weekly, 2021
  +4 more sources

Ivacaftor/lumacaftor

Reactions Weekly, 2023
openaire   +2 more sources

Ivacaftor/lumacaftor

Reactions Weekly, 2018
  +4 more sources

Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis

Drugs, 2016
Lumacaftor/ivacaftor (Orkambi™) is a fixed-dose tablet containing a corrector (lumacaftor) and potentiator (ivacaftor) of the cystic fibrosis transmembrane conductance regulator (CFTR) and is the first therapy approved to treat the underlying cause of cystic fibrosis in patients (aged ≥12 years) homozygous for the most common CFTR mutation, F508del ...
openaire   +2 more sources

Ivacaftor/lumacaftor

Reactions Weekly, 2022
openaire   +1 more source

Ivacaftor/ivacaftor/lumacaftor

Reactions Weekly, 2022
openaire   +1 more source

Lumacaftor (VX-809)

Drugs of the Future, 2012
null McPhail, G., null Clancy, J.P.
openaire   +1 more source

Brivaracetam, lumacaftor/ivacaftor, and deoxycholic acid

Journal of the American Pharmacists Association, 2016
Daniel A, Hussar, Jerry Rachel, George
openaire   +2 more sources